Monitoring Guidelines for Immunomodulatory Drug Therapy: Corticosteroids

The presentation discusses monitoring guidelines for the use of corticosteroids, emphasizing the need to balance their benefits against potential risks and complications. Corticosteroids have been utilized in clinical settings since the 1940s, acting swiftly to alleviate symptoms in various conditions, although some may resist steroid treatment. Key points include recognizing the side effects associated with corticosteroids, selecting appropriate regimens based on potency and route of administration, and implementing a proper tapering strategy to minimize adrenal suppression risk. The discussion highlights the importance of assessing bone health, cardiovascular status, endocrine function, gastrointestinal risk, and susceptibility to infections, with particular attention to conditions such as osteoporosis, diabetes, and potential infectious complications like PJP. Monitoring strategies involve regular screenings such as DEXA scans for bone density, blood pressure checks, diabetes screening, and assessing for peptic ulcer disease. The presentation also touches on specific patient considerations, including the impact of corticosteroids in pregnant individuals and those with concurrent health issues. A clinical case is presented to summarize the guidelines, illustrating how to implement them in a real-world scenario. Overall, the talk underscores the need for careful monitoring and patient education when prescribing corticosteroids to mitigate adverse outcomes.